P3 Health Partners Inc. (NASDAQ:PIII) Short Interest Down 51.3% in May

P3 Health Partners Inc. (NASDAQ:PIII) saw a large drop in short interest in the month of May. As of May 29th, there was short interest totaling 138,133 shares, a drop of 51.3% from the May 14th total of 283,541 shares. Currently, 2.3% of the company’s shares are sold short. Based on an average daily volume of 1,072,122 shares, the days-to-cover ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Weiss Ratings upgraded shares of P3 Health Partners from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, May 28th. Lake Street Capital reiterated a “buy” rating and issued a $14.00 price objective (up from $4.00) on shares of P3 Health Partners in a report on Friday, May 15th. TD Cowen reissued a “hold” rating and issued a $14.00 target price (up from $3.00) on shares of P3 Health Partners in a research note on Friday, May 22nd. Finally, UBS Group set a $14.00 target price on P3 Health Partners in a report on Friday, May 15th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, P3 Health Partners presently has a consensus rating of “Hold” and a consensus target price of $14.00.

P3 Health Partners Stock Down 9.8%

Shares of PIII opened at $12.23 on Friday. The stock has a market capitalization of $88.55 million, a P/E ratio of -0.32 and a beta of 1.60. P3 Health Partners has a twelve month low of $1.52 and a twelve month high of $16.89. The firm has a fifty day simple moving average of $6.88 and a two-hundred day simple moving average of $4.53.

P3 Health Partners (NASDAQ:PIII) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.85) by $5.17. The firm had revenue of $386.39 million for the quarter, compared to analysts’ expectations of $391.45 million. P3 Health Partners had a negative net margin of 8.57% and a negative return on equity of 302.33%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in P3 Health Partners stock. Lido Advisors LLC acquired a new position in P3 Health Partners Inc. (NASDAQ:PIII) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 10,748 shares of the company’s stock, valued at approximately $33,000. Lido Advisors LLC owned 0.15% of P3 Health Partners as of its most recent filing with the Securities and Exchange Commission. 7.75% of the stock is owned by hedge funds and other institutional investors.

P3 Health Partners Company Profile

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.